6533b7dbfe1ef96bd1270b3b

RESEARCH PRODUCT

The dual role of non-selective beta-blockers in cirrhotic patients: How do we know when Dr Jekyll turns into Mr Hyde?

Jean-paul CervoniBasile MouhatThierry ThevenotRomain Chopard

subject

medicine.medical_specialtyDual roleHepatologybusiness.industryLiver Cirrhosis AlcoholicInternal medicineAdrenergic beta-AntagonistsmedicineHumansBeta (finance)businessGastroenterologyFollow-Up Studies10.1111/liv.14770https://pubmed.ncbi.nlm.nih.gov/32979020